Analysis and Commentary STEVEN GROSSMAN 12/10/20 Analysis and Commentary STEVEN GROSSMAN 12/10/20 COVID-19 Vaccine Update: A Briefing from the FDA Read More Advocacy at a Glance STEVEN GROSSMAN 12/11/20 Advocacy at a Glance STEVEN GROSSMAN 12/11/20 FDA Commissioner and CBER Director Provide Insights on Vaccines at Alliance Briefing Read More Analysis and Commentary STEVEN GROSSMAN 9/18/20 Analysis and Commentary STEVEN GROSSMAN 9/18/20 Public Trust in the US FDA Read More Advocacy at a Glance STEVEN GROSSMAN 8/14/20 Advocacy at a Glance STEVEN GROSSMAN 8/14/20 Party Platforms Don’t Matter, Probably Read More Advocacy at a Glance STEVEN GROSSMAN 8/7/20 Advocacy at a Glance STEVEN GROSSMAN 8/7/20 What We Learned: A Meeting with CDER Deputy Center Director for Operations Dr. Patrizia Cavazzoni Read More Analysis and Commentary STEVEN GROSSMAN 7/10/20 Analysis and Commentary STEVEN GROSSMAN 7/10/20 CBER Director on COVID-19 and Vaccine Development Read More Analysis and Commentary STEVEN GROSSMAN 5/1/20 Analysis and Commentary STEVEN GROSSMAN 5/1/20 No Need for a Crystal Ball in Some Scenarios Read More
Analysis and Commentary STEVEN GROSSMAN 12/10/20 Analysis and Commentary STEVEN GROSSMAN 12/10/20 COVID-19 Vaccine Update: A Briefing from the FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 12/11/20 Advocacy at a Glance STEVEN GROSSMAN 12/11/20 FDA Commissioner and CBER Director Provide Insights on Vaccines at Alliance Briefing Read More
Analysis and Commentary STEVEN GROSSMAN 9/18/20 Analysis and Commentary STEVEN GROSSMAN 9/18/20 Public Trust in the US FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 8/14/20 Advocacy at a Glance STEVEN GROSSMAN 8/14/20 Party Platforms Don’t Matter, Probably Read More
Advocacy at a Glance STEVEN GROSSMAN 8/7/20 Advocacy at a Glance STEVEN GROSSMAN 8/7/20 What We Learned: A Meeting with CDER Deputy Center Director for Operations Dr. Patrizia Cavazzoni Read More
Analysis and Commentary STEVEN GROSSMAN 7/10/20 Analysis and Commentary STEVEN GROSSMAN 7/10/20 CBER Director on COVID-19 and Vaccine Development Read More
Analysis and Commentary STEVEN GROSSMAN 5/1/20 Analysis and Commentary STEVEN GROSSMAN 5/1/20 No Need for a Crystal Ball in Some Scenarios Read More
